Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2013

01.12.2013

Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure

verfasst von: Pietro Francia, Carmen Adduci, Agnese Ricotta, Rosita Stanzione, Isabella Sensini, Arianna Uccellini, Alessandra Frattari, Cristina Balla, Maria Cotugno, Riccardo Cappato, Speranza Rubattu, Massimo Volpe

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Defective Ca2+ handling in failing cardiomyocites predisposes patients with heart failure (HF) to ventricular arrhythmia. We investigated whether gene variants of Ca2+ handling proteins are associated with the occurrence of ventricular tachycardia/fibrillation (VT/VF) in HF patients implanted with a primary prevention implantable cardioverter-defibrillator (ICD).

Methods

One hundred thirty-six patients with HF were followed from ICD implantation to the time of first appropriate ICD intervention for VT > 170 bpm. The following polymorphisms were genotyped: ATP2A2 rs1860561 and rs56243033; RYR2 rs4142933; CASQ2 rs4074536; SLC8A1 g.-23449C > A; PLN rs12198461; FKBP1B rs7568163. Hazard ratios (HR) were derived from Cox proportional-hazards regression analysis.

Results

After a mean follow-up of 879 days (IQ range, 327 to 1,459), 34 patients (25 %) had appropriate ICD intervention. Non-sustained VT (HR, 2.12; 95 %CI, 0.87–5.19; p = 0.09) and atrial fibrillation (AF) at ICD implantation (HR, 2.33; 95 %CI, 0.89–6.10; p = 0.08) predicted appropriate ICD interventions with borderline statistical significance. Prevalence of ATP2A2 rs1860561 variant was 17 % in patients without VT/VF and 4 % in those with ventricular arrhythmia (p = 0.009). After adjustment for AF and NSVT, the rs1860561 A mutant allele independently predicted lower incidence of VT/VF (HR, 0.29; 95 %CI, 0.09–0.98; p = 0.04).

Conclusions

The observation that ATP2A2 rs1860561 gene variant associated with lower risk of life-threatening arrhythmia in HF patients suggests that selected calcium gene variants may modify the risk of SD even within the complex and polygenic pathological condition of HF. Combining traditional risk factors and genetic profiling could reveal helpful to identify HF patients who will benefit most from ICD implantation.
Literatur
1.
Zurück zum Zitat Mosterd, A., Hoes, A. W., de Bruyne, M. C., et al. (1999). Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. European Heart Journal, 20, 447–455.PubMedCrossRef Mosterd, A., Hoes, A. W., de Bruyne, M. C., et al. (1999). Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. European Heart Journal, 20, 447–455.PubMedCrossRef
2.
Zurück zum Zitat McMurray, J., McDonagh, T., Morrison, C. E., & Dargie, H. J. (1993). Trends in hospitalization for heart failure in Scotland 1980–1990. European Heart Journal, 14, 1158–1162.PubMedCrossRef McMurray, J., McDonagh, T., Morrison, C. E., & Dargie, H. J. (1993). Trends in hospitalization for heart failure in Scotland 1980–1990. European Heart Journal, 14, 1158–1162.PubMedCrossRef
3.
Zurück zum Zitat Cleland, J. G., Gemmell, I., Khand, A., & Boddy, A. (1999). Is the prognosis of heart failure improving? European Journal of Heart Failure, 1, 229–241.PubMedCrossRef Cleland, J. G., Gemmell, I., Khand, A., & Boddy, A. (1999). Is the prognosis of heart failure improving? European Journal of Heart Failure, 1, 229–241.PubMedCrossRef
4.
Zurück zum Zitat Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 106, 3068–3072.PubMedCrossRef Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 106, 3068–3072.PubMedCrossRef
5.
Zurück zum Zitat Cowie, M. R., Wood, D. A., Coats, A. J., et al. (2000). Survival of patients with a new diagnosis of heart failure: a population based study. Heart, 83, 505–510.PubMedCrossRef Cowie, M. R., Wood, D. A., Coats, A. J., et al. (2000). Survival of patients with a new diagnosis of heart failure: a population based study. Heart, 83, 505–510.PubMedCrossRef
6.
Zurück zum Zitat Moss, A. J., Hall, W. J., Cannom, D. S., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. The New England Journal of Medicine, 335, 1933–1940.PubMedCrossRef Moss, A. J., Hall, W. J., Cannom, D. S., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. The New England Journal of Medicine, 335, 1933–1940.PubMedCrossRef
7.
Zurück zum Zitat Moss, A. J., Zareba, W., Hall, W. J., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346, 877–883.PubMedCrossRef Moss, A. J., Zareba, W., Hall, W. J., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346, 877–883.PubMedCrossRef
8.
Zurück zum Zitat Bardy, G. H., Lee, K. L., Mark, D. B., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352, 225–237.PubMedCrossRef Bardy, G. H., Lee, K. L., Mark, D. B., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352, 225–237.PubMedCrossRef
9.
Zurück zum Zitat McMurray, J. J., Adamopoulos, S., Anker, S. D., et al. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33, 1787–1847.PubMedCrossRef McMurray, J. J., Adamopoulos, S., Anker, S. D., et al. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33, 1787–1847.PubMedCrossRef
10.
Zurück zum Zitat Yap, Y. G., & Duong, T. (2005). Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. European Heart Journal, 26, 1385–1393.PubMedCrossRef Yap, Y. G., & Duong, T. (2005). Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. European Heart Journal, 26, 1385–1393.PubMedCrossRef
11.
Zurück zum Zitat Scoote, M., & Williams, A. J. (2004). Myocardial calcium signalling and arrhythmia pathogenesis. Biochemical and Biophysical Research Communications, 322, 1286–1309.PubMedCrossRef Scoote, M., & Williams, A. J. (2004). Myocardial calcium signalling and arrhythmia pathogenesis. Biochemical and Biophysical Research Communications, 322, 1286–1309.PubMedCrossRef
12.
Zurück zum Zitat Francia, P., Balla, C., Uccellini, A., & Cappato, R. (2009). Arrhythmia detection in single- and dual-chamber implantable cardioverter defibrillators: the more leads, the better? Journal of Cardiovascular Electrophysiology, 20, 1077–1082.PubMedCrossRef Francia, P., Balla, C., Uccellini, A., & Cappato, R. (2009). Arrhythmia detection in single- and dual-chamber implantable cardioverter defibrillators: the more leads, the better? Journal of Cardiovascular Electrophysiology, 20, 1077–1082.PubMedCrossRef
13.
Zurück zum Zitat Kovlen, D. V., Tishakov, A. Y., Glotov, O. S., et al. (2007). Genetic determinants of the efficiency of climatotherapy in patients with chronic heart failure. Bulletin of Experimental Biology and Medicine, 143, 26–31.PubMedCrossRef Kovlen, D. V., Tishakov, A. Y., Glotov, O. S., et al. (2007). Genetic determinants of the efficiency of climatotherapy in patients with chronic heart failure. Bulletin of Experimental Biology and Medicine, 143, 26–31.PubMedCrossRef
14.
Zurück zum Zitat Kiec-Wilk, B., Olszanecka, A., Mikolajczyk, M., & Kawecka-Jaszcz, K. (2010). Role of the M235T (c.704c > T) polymorphism of angiotensynogen gene as well as A724A (c.2171G > A) polymorphism of SERCA2a gene in ethiopathogenesis of left ventricular hypertrophy in essential hypertension. Przegla̧d Lekarski, 67, 151–156.PubMed Kiec-Wilk, B., Olszanecka, A., Mikolajczyk, M., & Kawecka-Jaszcz, K. (2010). Role of the M235T (c.704c > T) polymorphism of angiotensynogen gene as well as A724A (c.2171G > A) polymorphism of SERCA2a gene in ethiopathogenesis of left ventricular hypertrophy in essential hypertension. Przegla̧d Lekarski, 67, 151–156.PubMed
15.
Zurück zum Zitat Kokubo, Y., Inamoto, N., Tomoike, H., et al. (2004). Association of genetic polymorphisms of sodium-calcium exchanger 1 gene, NCX1, with hypertension in a Japanese general population. Hypertension Research, 27, 697–702.PubMedCrossRef Kokubo, Y., Inamoto, N., Tomoike, H., et al. (2004). Association of genetic polymorphisms of sodium-calcium exchanger 1 gene, NCX1, with hypertension in a Japanese general population. Hypertension Research, 27, 697–702.PubMedCrossRef
16.
Zurück zum Zitat Sinner, M. F., Lubitz, S. A., Pfeufer, A., et al. (2011). Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm : The official journal of the Heart Rhythm Society, 8, 403–409.CrossRef Sinner, M. F., Lubitz, S. A., Pfeufer, A., et al. (2011). Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm : The official journal of the Heart Rhythm Society, 8, 403–409.CrossRef
17.
Zurück zum Zitat Gollob, M. H. (2011). The evolution of gene discovery and the revelation of truth. Heart Rhythm : The Official Journal of the Heart Rhythm Society, 8, 410–411.CrossRef Gollob, M. H. (2011). The evolution of gene discovery and the revelation of truth. Heart Rhythm : The Official Journal of the Heart Rhythm Society, 8, 410–411.CrossRef
18.
Zurück zum Zitat Darbar D. Genomics, heart failure and sudden cardiac death. Heart Fail Rev 2008. Darbar D. Genomics, heart failure and sudden cardiac death. Heart Fail Rev 2008.
19.
Zurück zum Zitat Gollob, M. H. (2006). Genetic profiling as a marker for risk of sudden cardiac death. Current Opinion in Cardiology, 21, 42–46.PubMedCrossRef Gollob, M. H. (2006). Genetic profiling as a marker for risk of sudden cardiac death. Current Opinion in Cardiology, 21, 42–46.PubMedCrossRef
20.
Zurück zum Zitat Sotoodehnia, N., Siscovick, D. S., Vatta, M., et al. (2006). Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation, 113, 1842–1848.PubMedCrossRef Sotoodehnia, N., Siscovick, D. S., Vatta, M., et al. (2006). Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation, 113, 1842–1848.PubMedCrossRef
21.
Zurück zum Zitat Chemello, D., Rohde, L. E., Santos, K. G., et al. (2010). Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure. Europace, 12, 686–691.PubMedCrossRef Chemello, D., Rohde, L. E., Santos, K. G., et al. (2010). Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure. Europace, 12, 686–691.PubMedCrossRef
22.
Zurück zum Zitat Bedi, M. S., Postava, L. A., Murali, S., et al. (2004). Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion/insertion polymorphism. Journal of Cardiovascular Electrophysiology, 15, 1162–1166.PubMedCrossRef Bedi, M. S., Postava, L. A., Murali, S., et al. (2004). Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion/insertion polymorphism. Journal of Cardiovascular Electrophysiology, 15, 1162–1166.PubMedCrossRef
23.
Zurück zum Zitat Sun, A. Y., Koontz, J. I., Shah, S. H., et al. (2011). The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction. Circulation Cardiovascular Genetics, 4, 163–168.PubMedCrossRef Sun, A. Y., Koontz, J. I., Shah, S. H., et al. (2011). The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction. Circulation Cardiovascular Genetics, 4, 163–168.PubMedCrossRef
24.
Zurück zum Zitat Periasamy, M., Bhupathy, P., & Babu, G. J. (2008). Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovascular Research, 77, 265–273.PubMedCrossRef Periasamy, M., Bhupathy, P., & Babu, G. J. (2008). Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovascular Research, 77, 265–273.PubMedCrossRef
25.
Zurück zum Zitat Ran, Y., Chen, J., Li, N., et al. (2010). Common RyR2 variants associate with ventricular arrhythmias and sudden cardiac death in chronic heart failure. Clinical Science, 119, 215–223.PubMed Ran, Y., Chen, J., Li, N., et al. (2010). Common RyR2 variants associate with ventricular arrhythmias and sudden cardiac death in chronic heart failure. Clinical Science, 119, 215–223.PubMed
26.
Zurück zum Zitat Arvanitis, D. A., Sanoudou, D., Kolokathis, F., et al. (2008). The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. European Heart Journal, 29, 2514–2525.PubMedCrossRef Arvanitis, D. A., Sanoudou, D., Kolokathis, F., et al. (2008). The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. European Heart Journal, 29, 2514–2525.PubMedCrossRef
27.
Zurück zum Zitat Nolte, I. M., Wallace, C., Newhouse, S. J., et al. (2009). Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One, 4, e6138.PubMedCrossRef Nolte, I. M., Wallace, C., Newhouse, S. J., et al. (2009). Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One, 4, e6138.PubMedCrossRef
28.
Zurück zum Zitat Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661–78. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661–78.
29.
Zurück zum Zitat The Diabetes Control and Complications Trial (DCCT). (1986). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes, 35, 530–545.CrossRef The Diabetes Control and Complications Trial (DCCT). (1986). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes, 35, 530–545.CrossRef
30.
Zurück zum Zitat Epidemiology of Diabetes Interventions and Complications. (1999). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care, 22, 99–111.CrossRef Epidemiology of Diabetes Interventions and Complications. (1999). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care, 22, 99–111.CrossRef
31.
Zurück zum Zitat Sakuntabhai, A., Burge, S., Monk, S., & Hovnanian, A. (1999). Spectrum of novel ATP2A2 mutations in patients with Darier's disease. Human Molecular Genetics, 8, 1611–1619.PubMedCrossRef Sakuntabhai, A., Burge, S., Monk, S., & Hovnanian, A. (1999). Spectrum of novel ATP2A2 mutations in patients with Darier's disease. Human Molecular Genetics, 8, 1611–1619.PubMedCrossRef
32.
Zurück zum Zitat Ejima, Y., Yang, L., & Sasaki, M. S. (2000). Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: a novel mutation target of microsatellite instability. International Journal of Cancer, 86, 262–268.CrossRef Ejima, Y., Yang, L., & Sasaki, M. S. (2000). Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: a novel mutation target of microsatellite instability. International Journal of Cancer, 86, 262–268.CrossRef
33.
Zurück zum Zitat Korosec, B., Glavac, D., Rott, T., & Ravnik-Glavac, M. (2006). Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genetics and Cytogenetics, 171, 105–111.PubMedCrossRef Korosec, B., Glavac, D., Rott, T., & Ravnik-Glavac, M. (2006). Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genetics and Cytogenetics, 171, 105–111.PubMedCrossRef
34.
Zurück zum Zitat Zhang, G. L., Li, M., Du, X. F., et al. (2011). A novel point mutation at donor splice-site in intron 18 of ATP2A2 gene resulting in the insertion of 27 nucleotides into the mature mRNA in a Chinese patient with severe Darier's disease. Journal of Dermatological Science, 64, 72–75.PubMedCrossRef Zhang, G. L., Li, M., Du, X. F., et al. (2011). A novel point mutation at donor splice-site in intron 18 of ATP2A2 gene resulting in the insertion of 27 nucleotides into the mature mRNA in a Chinese patient with severe Darier's disease. Journal of Dermatological Science, 64, 72–75.PubMedCrossRef
Metadaten
Titel
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure
verfasst von
Pietro Francia
Carmen Adduci
Agnese Ricotta
Rosita Stanzione
Isabella Sensini
Arianna Uccellini
Alessandra Frattari
Cristina Balla
Maria Cotugno
Riccardo Cappato
Speranza Rubattu
Massimo Volpe
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2013
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-013-9827-1

Weitere Artikel der Ausgabe 3/2013

Journal of Interventional Cardiac Electrophysiology 3/2013 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.